Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3829)
All Articles published online
|
Apr 14, 2008 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, Liu P, Li ZM. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein. World J Gastroenterol 2008; 14(14): 2251-2254 [PMID: 18407604 DOI: 10.3748/wjg.14.2251] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i14/2251.htm |
| Number | Citing Articles |
| 1 |
Juan Hu, Wubo Ren, Han Liu, Cong Xie, Dandan Li, Liping Yang, Fangli Liao, Linshan Jiang, Qinli Pu, Weixian Chen. Immunomultiple PCR-based electrochemical and lateral flow strategy for the simultaneous detection of liver cancer tumor markers. Microchimica Acta 2024; 191(1) doi: 10.1007/s00604-023-06098-y
|
| 2 |
Simona Gurzu, Rita Szodorai, Ioan Jung, Laura Banias. Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies. Journal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05781-8
|
| 3 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_36-1
|
| 4 |
Xiaoming Gong, Tao Chen, Cheyu Lin, Haiqin Ping, Xin Tong, Kai Zhang, Zhaojun Chen, Caiyun Cai, Zhiyan Lu, Hengning Ke, Yunfeng Zhao. Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/2501596
|
| 5 |
Bin Wang, Liang Chen, Hao-Teng Chang. Potential Diagnostic and Prognostic Biomarkers for Cholangiocarcinoma in Serum and Bile. Biomarkers in Medicine 2016; 10(6): 613 doi: 10.2217/bmm-2015-0062
|
| 6 |
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
|
| 7 |
An Integrated Framework to Identify Prognostic Biomarkers and Novel Therapeutic Targets in Hepatocellular Carcinoma-Based Disabilities. Biology 2024; 13(12): 966 doi: 10.3390/biology13120966
|
| 8 |
Xiaoyun Zhang, Yongjie Zhou, Zhenru Wu, Wei Peng, Chuan Li, Lvnan Yan, Jiayin Yang, Tianfu Wen. Double-Negative α-Fetoprotein and Carbohydrate Antigen 19-9 Predict a Good Prognosis in Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis. Clinical and Translational Gastroenterology 2021; 12(11): e00425 doi: 10.14309/ctg.0000000000000425
|
| 9 |
Kailiang Zhao, Xiaoquan Zhou, Yuchun Xiao, Yanni Wang, Lu Wen. Research Progress in Alpha-fetoprotein-induced Immunosuppression of Liver Cancer. Mini-Reviews in Medicinal Chemistry 2022; 22(17): 2237 doi: 10.2174/1389557522666220218124816
|
| 10 |
Jie Cao, Liang Huang, Caifeng Liu, Jing Li, Xianghua Zhang, Jun Shen, Jun Li, Lun Lu, Feng Xu, Jianjun Yan, Mengchao Wu, Wan Yee Lau, Yiqun Yan. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: A clinicopathologic study of 35 resected cases. Journal of Gastroenterology and Hepatology 2013; 28(6): 1025 doi: 10.1111/jgh.12143
|
| 11 |
Raynoo Thanan, Waleeporn Kaewlert, Chadamas Sakonsinsiri, Timpika Chaiprasert, Napat Armartmuntree, Duangkamon Muengsaen, Anchalee Techasen, Poramate Klanrit, Worachart Lert-itthiporn, Somchai Pinlaor, Chawalit Pairojkul. Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression. International Journal of Molecular Sciences 2020; 21(5): 1796 doi: 10.3390/ijms21051796
|
| 12 |
Jennifer Mbamalu Chinenye, Mercy Ekejindu Ifeoma, Bessie Enweani-Nwokelo Ifeoma, Ikechukwu Okeke Obiefuna, Amaechi Ofodile Chukwudi, Okorafor Kalu Stephen. Frequency of hepatitis C and D virus among chronic hepatitis B virus carriers in a Nigerian tertiary hospital. Journal of Public Health and Epidemiology 2022; 14(1): 10 doi: 10.5897/JPHE2021.1367
|
| 13 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 699 doi: 10.1007/978-3-319-26956-6_36
|
| 14 |
Lian-Yuan Tao, Lei Cai, Xiao-Dong He, Wei Liu, Qiang Qu. Comparison of Serum Tumor Markers for Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. The American Surgeon™ 2010; 76(11): 1210 doi: 10.1177/000313481007601119
|
| 15 |
Irene Y. Chen, Richard F. Dunne, Xiaoyan Liao. Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience. Virchows Archiv 2025; 486(2): 323 doi: 10.1007/s00428-024-03787-8
|
| 16 |
Álvaro Díaz-González, Alejandro Forner, María Reig, Jordi Bruix. Encyclopedia of Gastroenterology. 2020; : 151 doi: 10.1016/B978-0-12-801238-3.65714-8
|
| 17 |
Xin Zhang, Wen-Juan Huang, Meng-Lin Zhang, Wen Wang, Ye Niu, Rui-tao Wang, Zeng-yao Liu. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02348-0
|
| 18 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
|
| 19 |
Yu‑Xue Gao, Tong‑Wang Yang, Ji‑Ming Yin, Peng‑Xiang Yang, Bu‑Xin Kou, Meng‑Yin Chai, Xiao‑Ni Liu, De‑Xi Chen. Progress and prospects of biomarkers in�primary liver cancer (Review). International Journal of Oncology 2020; doi: 10.3892/ijo.2020.5035
|
| 20 |
Dengqiang Wu, Yujie Li. Application of adoptive cell therapy in hepatocellular carcinoma. Immunology 2023; 170(4): 453 doi: 10.1111/imm.13677
|
| 21 |
Xiaoping Wang, Caifei Shen, Jianjiang Yang, Xianjun Yang, Sen Qin, Haijun Zeng, Xiaoling Wu, Shanhong Tang, Weizheng Zeng. Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/1232785
|
| 22 |
Johnathan Abou-Fadel, Victoria Reid, Alexander Le, Jacob Croft, Jun Zhang. Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers. Diagnostics 2023; 13(6): 1012 doi: 10.3390/diagnostics13061012
|
| 23 |
Meng-Meng Qu, Yuan-Hui Zhu, Yi-Xiang Li, Zhi-Fan Li, Jin-Kui Li, Yong-Sheng Xu, Manishkumar Shrestha, Jun-Qiang Lei. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Medicine 2021; 100(46): e27349 doi: 10.1097/MD.0000000000027349
|
| 24 |
Rita Szodorai, Emőke Fülöp, Andrei Fülöp, Radu Mircea Neagoe, Simona Gurzu. Synchronous Hepatocellular and Intrahepatic Cholangiocellular Carcinoma With Predominant Ductal Plate Malformation Pattern. A Case Report and Review of the Literature. Cancer Reports 2025; 8(2) doi: 10.1002/cnr2.70085
|
| 25 |
Krzysztof Jakimów, Natalia Tekiela, Katarzyna Kozak, Robert Peterek, Anna Kwaśniewska, Jacek Pająk, Jerzy Chudek. Misdiagnosis Based on Neoplastic Markers—Extremely High Alpha-Fetoprotein in Patients with Intrahepatic Cholangiocarcinoma with Literature Review of the Published Cases. Medicina 2024; 60(7): 1109 doi: 10.3390/medicina60071109
|
| 26 |
Zhizhen Li, Lei Yuan, Chen Zhang, Jiaxing Sun, Zeyuan Wang, Yu Wang, Xin Hao, Fei Gao, Xiaoqing Jiang. A Novel Prognostic Scoring System of Intrahepatic Cholangiocarcinoma With Machine Learning Basing on Real-World Data. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.576901
|
| 27 |
Zhiting Lao, Shuanqi Li, Jinhui Liang, Jingyi Su, Xin Gong, Xiping Cui, Suqing Zhao. Production and characterization of GPC3-N protein and its nanobody. Protein Expression and Purification 2022; : 106094 doi: 10.1016/j.pep.2022.106094
|
| 28 |
Hong-Yang Li, Shi-Ji Zhou, Min Li, Ding Xiong, Akanand Singh, Qing-Xi Guo, Chang-An Liu, Jian-Ping Gong. Diagnosis and Cure Experience of Hepatolithiasis-Associated Intrahepatic Cholangiocarcinoma in 66 Patients. Asian Pacific Journal of Cancer Prevention 2012; 13(2): 725 doi: 10.7314/APJCP.2012.13.2.725
|
| 29 |
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?. World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
|
| 30 |
|
| 31 |
Rondell P. Graham, Emily G. Barr Fritcher, Ekaterina Pestova, John Schulz, Leonid A. Sitailo, George Vasmatzis, Stephen J. Murphy, Robert R. McWilliams, Steven N. Hart, Kevin C. Halling, Lewis R. Roberts, Gregory J. Gores, Fergus J. Couch, Lizhi Zhang, Mitesh J. Borad, Benjamin R. Kipp. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. Human Pathology 2014; 45(8): 1630 doi: 10.1016/j.humpath.2014.03.014
|
| 32 |
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
|